20
Participants
Start Date
January 31, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
tPA
IV tPA 0.9 mg/kg maximum of 90 mg. Administered by standard protocol. 10% of the dose by intravenous bolus injection, followed by infusion of the remainder over an hour. Treatment will be initiated within 4.5 hours of awakening with preferred target door to needle time of 60 minutes or less from ED arrival.
Johns Hopkins Bayview Medical Center, Baltimore
The Johns Hopkins Hospital, Baltimore
Collaborators (1)
Genentech, Inc.
INDUSTRY
Johns Hopkins University
OTHER